Cargando…

Symptom prevalence and secondary attack rate of SARS‐CoV‐2 in rural Kenyan households: A prospective cohort study

BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallagher, Katherine E., Nyiro, Joyce, Agoti, Charles N., Maitha, Eric, Nyagwange, James, Karani, Angela, Bottomley, Christian, Murunga, Nickson, Githinji, George, Mutunga, Martin, Ochola‐Oyier, Lynette Isabella, Kombe, Ivy, Nyaguara, Amek, Kagucia, E. Wangeci, Warimwe, George, Agweyu, Ambrose, Tsofa, Benjamin, Bejon, Philip, Scott, J. Anthony G., Nokes, David James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522480/
https://www.ncbi.nlm.nih.gov/pubmed/37752066
http://dx.doi.org/10.1111/irv.13185
Descripción
Sumario:BACKGROUND: We estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission. METHODS: We enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood sample, and naso‐oropharyngeal swabs were collected. Household members were followed 4, 7, 10, 14, 21 and 28 days after the date of the first PCR‐positive in the household; naso‐oropharyngeal swabs were collected at each visit and used to define secondary cases. Blood samples were collected every 1–2 weeks. Symptoms were collected in a daily symptom diary. We used binomial regression to estimate secondary attack rates and survival analysis to analyse risk factors for transmission. RESULTS: A total of 119 households with at least one positive household member were enrolled between October 2020 and September 2022, comprising 503 household members; 226 remained in follow‐up at day 14 (45%). A total of 43 secondary cases arose within 14 days of identification of the primary case, and 81 household members remained negative. The 7‐day secondary attack rate was 4% (95% CI 1%–10%), the 14‐day secondary attack rate was 28% (95% CI 17%–40%). Of 38 secondary cases with data, eight reported symptoms (21%, 95% CI 8%–34%). Antibody to SARS‐CoV‐2 spike protein at enrolment was not associated with risk of becoming a secondary case. CONCLUSION: Households in our setting experienced a lower 7‐day attack rate than a recent meta‐analysis indicated as the global average (23%–43% depending on variant), and infection is mostly asymptomatic in our setting.